The relapse of brain tumours after therapy is driven by cancer stem cells that were not affected by the treatment. In mouse models of glioblastoma, scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) were now...
Original Article: Enzyme responsible for dangerous properties of brain tumour stem cells